Clinical Trials in Salt Lake City

Showing 1441-1460 of 16,694 trials

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

NCT04283149

This objective of this study is to evaluate the safety, and to collect supportive data on effectiveness of the EVO/EVO+ Visian® Implantable Collamer® Lens (ICL) in study participants who have a diagnosis of myopia or myopia with astigmatism. Primary study analysis will be evaluated when 300 primary eyes complete 6 months of follow-up. Final study analysis will be assessed when all treated eyes complete 36 months of follow-up.

MyopiaMyopic Astigmatism

Staar Surgical Company327 participantsStarted Jan 2020

Phoenix, Arizona, United States • Honolulu, Hawaii, United States • Indianapolis, Indiana, United States +11 more locations

Not Yet RecruitingNA29 miles

Essential Oil Inhalation and Acute Stress Response in Healthy Adults

NCT07473544

This randomized, double-blind, placebo-controlled study evaluates the acute physiological and subjective responses to essential oil inhalation in healthy adults. Participants are assigned to inhale either an essential oil or a placebo via an aroma stick during standardized laboratory procedures designed to induce temporary psychosocial stress (Trier Social Stress Test - Group version) and during a guided relaxation session. Physiological responses, including heart rate, heart rate variability, and electrodermal activity, are measured using a wearable sensor. Subjective stress and affect are assessed using validated questionnaires and visual analog scales. The purpose of this study is to characterize short-term autonomic and self-reported responses associated with essential oil inhalation under controlled experimental conditions. This study is exploratory and is not intended to diagnose, treat, or prevent any medical condition.

Psychological Stress

dōTERRA International200 participantsStarted Mar 2026

Pleasant Grove, Utah, United States

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Essential Oil Inhalation and Acute Stress Response in Healthy Adults

Find Trials by Condition in Salt Lake City

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Objective Assessment of Intraocular Lens Tilt and Decentration

Comparison of Methods for Assessing Intraocular Lens Position

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Safety of RSV Preventive Monoclonal Antibody

A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies